Drug intelligence / Profile preview

diltiazem + niclosamide

Development stage
Unknown
Lead developer
Mitsubishi Tanabe Pharma
Modality
Small Molecules
Administration
Oral (for Both Components)
01

Overview

This is a combination of two small molecule drugs, diltiazem and niclosamide. Diltiazem is a non-dihydropyridine calcium channel blocker primarily used to treat hypertension, angina, and certain cardiac arrhythmias by inhibiting calcium influx into cardiac and vascular smooth muscle during depolarization. Niclosamide is an anthelmintic agent indicated for the treatment of tapeworm infections; it acts by inhibiting oxidative phosphorylation in the mitochondria of parasites, leading to their death. There are no known approved fixed-dose combination products containing both agents; this entry describes the theoretical or investigational use of these two drugs together.

02

Targets

NeuraminidaseCACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on diltiazem + niclosamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diltiazem + niclosamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call